AR065034A1 - METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS - Google Patents

METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS

Info

Publication number
AR065034A1
AR065034A1 ARP080100311A ARP080100311A AR065034A1 AR 065034 A1 AR065034 A1 AR 065034A1 AR P080100311 A ARP080100311 A AR P080100311A AR P080100311 A ARP080100311 A AR P080100311A AR 065034 A1 AR065034 A1 AR 065034A1
Authority
AR
Argentina
Prior art keywords
prevent
methods
neurodegenerative disorders
treat neurodegenerative
patient
Prior art date
Application number
ARP080100311A
Other languages
Spanish (es)
Inventor
Weitesrstadt Wienrich
Jurgen Reess
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39315016&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR065034(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR065034A1 publication Critical patent/AR065034A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método para tratar, prevenir o ralentizar, retrasar o invertir el avance dc uno o mas trastornos neurodegencrativos en un paciente que lo necesite, caracterizado por la administracion de un derivado de benceno sustituido con glucopiranosilo, uno de sus tautomeros, estercoisorneros, mezcIas o sales, corno se define en la reivindicacion 1, al paciente que lo necesita.A method to treat, prevent or slow down, delay or reverse the progress of one or more neurodegentric disorders in a patient in need, characterized by the administration of a benzene derivative substituted with glucopyranosyl, one of its tautomers, stercoisorneros, mixtures or salts , as defined in claim 1, to the patient in need.

ARP080100311A 2007-01-26 2008-01-25 METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS AR065034A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07101213 2007-01-26

Publications (1)

Publication Number Publication Date
AR065034A1 true AR065034A1 (en) 2009-05-13

Family

ID=39315016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100311A AR065034A1 (en) 2007-01-26 2008-01-25 METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS

Country Status (4)

Country Link
AR (1) AR065034A1 (en)
CL (1) CL2008000223A1 (en)
TW (1) TW200843785A (en)
WO (1) WO2008090209A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087843A1 (en) * 2001-09-05 2003-05-08 Washburn William N. O-pyrazole glucoside SGLT2 inhibitors and method of use
CA2539032A1 (en) * 2003-08-26 2005-03-10 Boehringer Ingelheim International Gmbh Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof
DE102004058449A1 (en) * 2004-12-03 2006-06-14 Merck Patent Gmbh tetrahydropyran
JP2008007405A (en) * 2004-12-07 2008-01-17 Takeda Chem Ind Ltd Carboxamide derivative
US8845999B2 (en) * 2005-05-23 2014-09-30 The Regents Of The University Of California Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease
UY29694A1 (en) * 2005-07-28 2007-02-28 Boehringer Ingelheim Int METHODS TO PREVENT AND TREAT METABOLIC AND NEW DISORDERS DERIVED FROM PIRAZOL-O-GLUCOSIDO

Also Published As

Publication number Publication date
WO2008090209A3 (en) 2008-10-02
TW200843785A (en) 2008-11-16
CL2008000223A1 (en) 2008-05-23
WO2008090209A2 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
AR065034A1 (en) METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS
AR065033A1 (en) METHODS TO PREVENT AND TREAT NEURODEGENERATIVE DISORDERS
CY1121135T1 (en) SUBSTITUTED FOUR-CYCLINES COMPOUNDS FOR THE TREATMENT OF INFLAMMATIVE SKIN DISORDERS
CY1118308T1 (en) PHARMACEUTICAL COMPOSITION INCLUDING BENZZOLI PRODUCER SUBSTITUTED WITH GLYCOPYROZONZYL
GT201200250A (en) ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE
PA8770101A1 (en) AMIDAS OF 4-ARIL-1,4-DIHIDRO-1, 6-NAFTIRIDINE SUBSTITUTED AND ITS USE
ECSP067021A (en) COMPOUNDS AND COMPOSITIONS AS RECEPTOR MODULATORS ACTIVATED BY PEROXISOM PROLIFERATOR (PPAR)
GT200800151A (en) 11-BETA-HSD1 INHIBITORS
CR20110077A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
BR112015023349A2 (en) compound, pharmaceutical composition, and method of treating a disease, health condition or disorder
CO6440531A2 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
CO6280490A2 (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE
ECSP099413A (en) BASED COMPOUNDS OF 4 - Phenyl - 6 - (2,2,2 - Trifluoro - 1 - Phenylethoxy) pyrimidine AND METHODS FOR USE
DOP2010000062A (en) CICLOPROPILAMIDE DERIVATIVES
CL2011002185A1 (en) Compounds n, n-dimethyl-5- (2-methyl-6 - ((5-methylpyrazin-2-yl) -carbamoyl) benzofuran-4-yloxy) pyrimidin-2-carboxamide and salts thereof; pharmaceutical composition that includes them; and its use as activators of glucokinase to treat obesity and to treat or delay the progression or onset of type 2 diabetes and related disorders.
GT201400111A (en) SUBSTITUTED TRIAZOLOPIRIDINS
CR20110103A (en) HETEROARILOS SUBSTITUTED
UY29735A1 (en) PIPERAZINAS REPLACED AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
ECSP067019A (en) COMPOUNDS AND COMPOSITIONS AS RECEPTOR MODULATORS ACTIVATED BY PEROXISOM PROLIFERATOR (PPAR)
CL2008002826A1 (en) Alkylthio substituted pyrimidine derivative compounds, crth2 antagonist; pharmaceutical composition comprising said compounds; and use to treat an allergic disease, asthma, atopic dermatitis, psoriasis, ulcerative colitis, sinusitis, basophilic leukemia, among others.
BRPI0810130A8 (en) BEVERAGE COMPOSITION, PROCESS FOR PRODUCING A BEVERAGE COMPOSITION, AND, USE OF A BEVERAGE COMPOSITION
DOP2010000321A (en) IMINOPIRIMIDINE DERIVATIVES AND THEIR USE
UY31133A1 (en) "SUBSTITUTED OXAZOLIDINONES AND ITS USE"

Legal Events

Date Code Title Description
FB Suspension of granting procedure